-
ANIP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
ANI Pharmaceuticals (ANIP)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 145.02 mm | 145.02 mm | 145.02 mm | 145.02 mm | 145.02 mm | 145.02 mm |
Cash burn (monthly) | 31.70 mm | 4.01 mm | 10.50 mm | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 136.98 mm | 17.31 mm | 45.37 mm | n/a | n/a | n/a |
Cash remaining | 8.03 mm | 127.71 mm | 99.64 mm | n/a | n/a | n/a |
Runway (months of cash) | 0.3 | 31.9 | 9.5 | n/a | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 208 |
Opened positions | 38 |
Closed positions | 33 |
Increased positions | 86 |
Reduced positions | 43 |
13F shares | Current |
---|---|
Total value | 1.09 tn |
Total shares | 21.26 mm |
Total puts | 10.50 k |
Total calls | 11.70 k |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 2.69 mm | $160.47 bn |
Meridian Venture Partners II GP | 1.42 mm | $94.45 mm |
Vanguard | 1.35 mm | $80.43 bn |
Esjay | 932.62 k | $48.92 mm |
GS The Goldman Sachs Group, Inc. | 716.07 k | $42.72 bn |
STT State Street | 703.84 k | $41.99 bn |
Dimensional Fund Advisors | 655.31 k | $39.09 bn |
Ranger Investment Management | 589.69 k | $35.18 bn |
Pacer Advisors | 568.34 k | $33.91 bn |
JPM JPMorgan Chase & Co. | 554.84 k | $33.10 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jan 25 | Meredith Cook | Common Stock | Sell | Dispose S | No | Yes | 53.92 | 400 | 21.57 k | 55,588 |
17 Dec 24 | Carey Stephen P. | Common Stock | Sell | Dispose S | No | No | 55.79 | 7,500 | 418.43 k | 154,468 |
13 Dec 24 | Meredith Cook | Common Stock | Sell | Dispose S | No | Yes | 56.24 | 250 | 14.06 k | 55,988 |
11 Dec 24 | Krista Davis | Common Stock | Sell | Dispose S | No | Yes | 60 | 1,000 | 60.00 k | 49,059 |
26 Nov 24 | Nikhil Lalwani | Common Stock | Sell | Dispose S | No | No | 58.3 | 3,481 | 202.94 k | 370,378 |
26 Nov 24 | Nikhil Lalwani | Common Stock | Sell | Dispose S | No | No | 57.95 | 30,000 | 1.74 mm | 373,859 |
26 Nov 24 | Nikhil Lalwani | Common Stock | Option exercise | Acquire M | No | No | 29 | 30,000 | 870.00 k | 403,859 |
26 Nov 24 | Nikhil Lalwani | Stock Option Common Stock | Option exercise | Dispose M | No | No | 29 | 30,000 | 870.00 k | 138,027 |